Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

British Journal of Cancer

Volumn 87, Issue 10, 2002, Pages 1066-1071

  Bokemeyer, Carsten ^a   Oechsle, K ^a   Hartmann, J T ^a   Schoffski P ^b   Schleucher, N ^c   Metzner, B ^d   Schleicher, J ^e   Kanz, L ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d KLINIKUM OLDENBURG   (Germany)

^e Katharinenhospital Stuttgart ^*  (Germany)

Author keywords

Anaemia; Autologous blood stem cell transplantation; Chemotherapy; Cisplatin; Germ cell tumour; Prognostic factors

Indexed keywords

CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ACUTE TOXICITY; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHILD; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; GERM CELL TUMOR; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; STEM CELL TRANSPLANTATION; TESTIS CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GERMINOMA; HEMOGLOBINS; HUMANS; MALE; NEOPLASM METASTASIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TESTICULAR NEOPLASMS; THROMBOCYTOPENIA; TRANSPLANTATION, AUTOLOGOUS;

EID: 0037021266     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600629     Document Type: Article

References (23)

1. Adamson JW, Ludwig H (1999) Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anaemia of cancer. Oncology 56: 46-53
2. Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E (2000) Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 82: 93-97
3. Bokemeyer C, Harstrick A, Beyer J, Metzner B, Ruther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schoffski P, Kuhrer I, Illiger HJ, Kempf B, Reichle A, Foller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pfluger KH, Ostermann H, Kanz L, Schmoll HJ (1998) The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Semin Oncol 25: 24-32
4. Bokemeyer C, Kollmannsberger C, Meisner C, Harstrick A, Beyer J, Metzner B, Hartmann JT, Schmoll HJ, Einhorn L, Kanz L, Nichols C (1999) First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol 17: 3450-3456
5. Crawford J, Foote M, Morstyn G (1999) Hematopoietic growth factors in cancer chemotherapy. Cancer Chemother Biol Response Modif 18: 250-267
6. Eguchi K (1995) Management of chemotherapy-induced anemia. Curr Opin Oncol 7: 316-319
7. Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH (2001) Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19: 2875-2882
8. Groopman JE, Itri LM (1999) Chemotherapy-induced anaemia in adults: Incidence and treatment. J Natl Cancer Inst 91: 1616-1634
9. Haensgen G, Krause U, Becker A, Stadler P, Lautenschlager C, Wohlrab W, Rath FW, Molls M, Dunst J (2001) Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys 15: 865-872
10. Hartmann JT, Kanz L, Bokemeyer C (1999) Diagnosis and treatment of patients with testicular germ cell cancer. Drugs 58: 257-281
11. Henry DH (1998) Epoetin alfa and high-dose chemotherapy. Semin Oncol 25: 54-57
12. IGCCCG, (1997) International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15: 594-603
13. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19: 2865-2874
14. Ludwig H, Fritz E (1998) Anaemia of cancer patients: Patient selection and patient stratification for epoetin treatment. Semin Oncol 25: 35-38
15. Manegold C (1998) The causes and prognostic significance of low hemoglobin levels in tumor patients. Strahlenther Onkol 174:(Suppl): 417-419
16. Mercadante S, Gebbia V, Marrazzo A, Filosto S (2000) Anaemia in cancer: Pathophysiology and treatment. Cancer Treat Rev 26: 303-311
17. Obermair A, Handisurya A, Kaider A, Sevelda P, Kolbl H, Gitsch G (1998) The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: A prospective review. Cancer 83: 726-731
18. Pivot X, Guardiola E, Etienne M, Thyss A, Foa C, Otto J, Schneider M, Magne N, Bensadoun RJ, Renee N, Milano G (2000) An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia. Eur J Cancer 36: 852-857
19. Ponchio L, Zambelli A, De Stefano A, Robustelli-Della-Cuna FS, Perotti C, Pedrazzoli P (2000) Transfusion requirement can be abolished by epoietin-a and autologous platelet predeposit in patients receiving high dose chemotherapy with stem cell support. Haematologica 85: 219-220
20. Ray-Coquard I, Le Cesne A, Rubio MT, Mermet J, Maugard C, Ravaud A, Chevreau C, Sebban C, Bachelot T, Biron P, Blay JY (1999) Risk model for severe anaemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group. J Clin Oncol 17: 2840-2846
21. Sonneveld DJ, Hoekstra HJ, van der Graaf WT, Sluiter WJ, Mulder NH, Willemse PH, Koops HS, Sleijfer DT (2001) Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era. Cancer 91: 1304-1315
22. Thatcher N (1998) Management of chemotherapy-induced anaemia in solid tumors. Semin Oncol 25: 23-26
23. Thatcher N, De Campos ES, Bell DR, Steward WP, Varghese G, Morant R, Vansteenkiste JF, Rosso R, Ewers SB, Sundal E, Schatzmann E, Stocker H (1999) Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer 80: 396-402